SCHEMBL5184337

SCHEMBL5184337

CC(C)n1sc(-c2ccccc2)c(NCCCCc2ccccc2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
SIGMAR1 Q99720 7/20 0.40
KMT2A Q03164 5/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
ASAH1 Q13510 3/20 0.39
MEN1 O00255 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TYMP P19971 1/20 0.38
GPR84 Q9NQS5 1/20 0.38
ASPH Q12797 1/20 0.38
KDM8 Q8N371 1/20 0.38
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
THRB P10828 1/20 0.37
APEX1 P27695 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5197239 0.84 GSK3B (0.43) MAOAMAOBKMT2AALDH1A1MEN1
SCHEMBL5185824 0.84 NPBWR1 (0.43) KMT2AALDH1A1HPGDMEN1L3MBTL1
SCHEMBL17844110 0.81 MAOA (0.40) MAOAMAOBSIGMAR1KMT2AASAH1
SCHEMBL5184329 0.81 TYMP (0.42) MAOAMAOBSIGMAR1KMT2AASAH1
SCHEMBL17844146 0.79 HTR1B (0.39) SIGMAR1L3MBTL1GPR84LMNA
SCHEMBL17844216 0.76 EPHX1 (0.40) MAOAMAOBKMT2AASAH1MEN1
SCHEMBL17844226 0.75 MAPK1 (0.37) KMT2AALDH1A1HPGDMEN1LMNA
SCHEMBL17844238 0.75 SMN1; SMN2 (0.43) KMT2AALDH1A1HPGDMEN1L3MBTL1
SCHEMBL17844195 0.73 ASPH (0.41) MAOAMAOBKMT2AALDH1A1HPGD
SCHEMBL5224541 0.73 GBA1 (0.44) ALDH1A1ASAH1ASPHKDM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016100619-A2 TREATMENT AND DIAGNOSIS OF CANCER RGENIX, INC. (US) 2016-06-23 WO disclosed
EP-1838687-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073366-A1 NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed